Quest Diagnostics, French agency seek to expand breast cancer gene database
April 21, 2015 at 00:01 AM EDT
NEW YORK, April 21 (Reuters) - Quest Diagnostics Inc , the world's largest provider of diagnostic testing services, is working with France's national health agency to build an expanded database for BRCA1 and BRCA2 gene mutations to better determine patient hereditary risks of breast and ovarian cancer.